GlassScriptPhysician profile
Omar H Henriquez
NPI 1306072004
$3,943.63
in general payments reported to CMS, 2019-2025
28 companies · $2,035 in 2025
The $2,035 reported for 2025 was more than what 79% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $358 · 2020: $47.11 · 2021: $106 · 2022: $237 · 2023: $762 · 2024: $398 · 2025: $2,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,992 · Travel and Lodging: $1,203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,991.50 |
| Travel and Lodging | $1,203.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $1,394.45 | 2025 | Ha Minuteman G3-R |
| Nevro Corp. | $375.74 | 2019-2024 | Senza |
| Abbvie INC. | $253.83 | 2022-2024 | |
| Boston Scientific Corporation | $240.35 | 2019-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, Intracept |
| Depuy Synthes Sales INC. | $230.88 | 2023 | Confidence Spinal Cement System, Sentio |
| Saluda Medical Americas, INC. | $191.21 | 2023-2025 | Evoke Scs, Evoke |
| Mml US, INC. | $183.64 | 2025 | Reactiv8 |
| Abbott Laboratories | $183.23 | 2019-2025 | Eterna, Proclaim |
| Curonix LLC | $173.33 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic, INC. | $171.44 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.96 | 2024-2025 | Relistor |
| Fidia Pharma USA INC. | $55.18 | 2019-2024 | Hym/Hyn |
| Kowa Pharmaceuticals America, INC. | $53.56 | 2023 | Seglentis |
| Almatica Pharma LLC | $50.99 | 2022 | |
| Painteq LLC | $44.09 | 2023-2024 | Painteq |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $39.56 | 2019-2021 | |
| Vertos Medical, INC. | $34.57 | 2023-2024 | Mild Device Kit |
| Spr Therapeutics, INC | $29.19 | 2024 | Sprint Pns System |
| Nalu Medical, INC. | $21.68 | 2025 | Nalu Neurostimulation System |
| Globus Medical, INC. | $20.24 | 2025 | Senza |
| Foundation Fusion Solutions, LLC | $20.05 | 2025 | |
| Alnylam Pharmaceuticals INC. | $19.92 | 2024 | Givlaari |
| Biodelivery Sciences International, INC. | $18.16 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $18.03 | 2023 | Zilretta, Iovera |
| Forte Bio-Pharma LLC | $16.17 | 2024 | Prolate, Nalocet |
| Medline Industries LP | $15.72 | 2023 | |
| Amgen INC. | $13.61 | 2019 | |
| Pfizer INC. | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Henriquez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.